Literature DB >> 30188112

Quercetin Inlaid Silk Fibroin/Hydroxyapatite Scaffold Promotes Enhanced Osteogenesis.

Jeong Eun Song1, Nirmalya Tripathy2, Dae Hoon Lee1, Jong Ho Park1, Gilson Khang1.   

Abstract

There is a significant rise in the bone grafts demand worldwide to treat bone defects owing to continuous increase in conditions such as injury, trauma, diseases, or infections. Therefore, development of three-dimensional scaffolds has evolved as a reliable technology to address the current limitations for bone tissue regeneration. Mimicking the natural bone, in this study, we have designed a silk fibroin/hydroxyapatite scaffold inlaid with a bioactive phytochemical (quercetin) at different concentrations for promoting osteogenesis, especially focusing on quercetin ability for enhancing bone health. Characterization of the quercetin/silk fibroin/hydroxyapatite (Qtn/SF/HAp) scaffolds showed an increased pore size and irregular porous microstructure with good mechanical strength. The Qtn (low-content)/SF/HAp scaffold was found to be an efficient cell carrier facilitating cellular growth, osteogenic differentiation, and proliferation as compared to SF/HAp and Qtn (high-content)/SF/HAp scaffolds. However, Qtn (high-content)/SF/HAp was observed to inhibit cell proliferation without any effects on cell viability. In vitro and in vivo outcomes studied using bone marrow-derived mesenchymal stem cells (rBMSCs) confirm the cytocompatibility, osteogenic differentiation ability, and prominent upregulation of the bone-specific gene expressions for the rBMSCs-seeded Qtn/SF/HAp scaffolds. In particular, the implanted Qtn (low-content)/SF/HAp scaffolds at the bone defect site were found to be well-attached and amalgamated with the surrounding tissues with approximately 80% bone volume recovery at 6 weeks after surgery as compared with other groups. Based on the aforementioned observations highlighting the quercetin efficiency for bone regeneration, the as-synthesized Qtn (low-content)/SF/HAp scaffolds can be envisioned to provide a biomimetic bone-like microenvironment promoting rBMSCs differentiation into osteoblast, thus suggesting a potential alternative graft for high-performance regeneration of bone tissues.

Entities:  

Keywords:  bone marrow-derived mesenchymal stem cells; osteogenic differentiation; quercetin; scaffolds; silk fibroin/hydroxyapatite

Mesh:

Substances:

Year:  2018        PMID: 30188112     DOI: 10.1021/acsami.8b08119

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  9 in total

1.  Gaseous sulfur trioxide induced controllable sulfonation promoting biomineralization and osseointegration of polyetheretherketone implants.

Authors:  Teng Wan; Zixue Jiao; Min Guo; Zongliang Wang; Yizao Wan; Kaili Lin; Qinyi Liu; Peibiao Zhang
Journal:  Bioact Mater       Date:  2020-07-04

2.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis.

Authors:  Tongtong Zhu; Yutao Cui; Mingran Zhang; Duoyi Zhao; Guangyao Liu; Jianxun Ding
Journal:  Bioact Mater       Date:  2020-04-17

3.  Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo.

Authors:  Shibo Liu; Hao Zhou; Hanghang Liu; Huanzhong Ji; Wei Fei; En Luo
Journal:  Cell Prolif       Date:  2019-04-10       Impact factor: 6.831

4.  Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.

Authors:  Xiaoyue Sun; Jie Zhang; Zijun Wang; Bingqian Liu; Shenting Zhu; Lingxin Zhu; Bin Peng
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 5.  Traditional Chinese Medicine Compound-Loaded Materials in Bone Regeneration.

Authors:  Guiwen Shi; Chaohua Yang; Qing Wang; Song Wang; Gaoju Wang; Rongguang Ao; Dejian Li
Journal:  Front Bioeng Biotechnol       Date:  2022-02-18

6.  Surface modification of titanium substrate via combining photothermal therapy and quorum-sensing-inhibition strategy for improving osseointegration and treating biofilm-associated bacterial infection.

Authors:  Jingwei Hu; Yao Ding; Bailong Tao; Zhang Yuan; Yulu Yang; Kun Xu; Xuan Li; Peng Liu; Kaiyong Cai
Journal:  Bioact Mater       Date:  2022-03-16

7.  Sustained release of naringin from silk-fibroin-nanohydroxyapatite scaffold for the enhancement of bone regeneration.

Authors:  Zhi-Hu Zhao; Xin-Long Ma; Jian-Xiong Ma; Jia-Yu Kang; Yang Zhang; Yue Guo
Journal:  Mater Today Bio       Date:  2022-01-23

Review 8.  The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Jinli Zhang; Zhihe Liu; Yang Luo; Xiaojian Li; Guowei Huang; Huan Chen; Aiguo Li; Shengnan Qin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

9.  Mesenchymal stem cell-loaded thermosensitive hydroxypropyl chitin hydrogel combined with a three-dimensional-printed poly(ε-caprolactone) /nano-hydroxyapatite scaffold to repair bone defects via osteogenesis, angiogenesis and immunomodulation.

Authors:  Xiongfa Ji; Xi Yuan; Limin Ma; Bo Bi; Hao Zhu; Zehua Lei; Wenbin Liu; HongXu Pu; Jiawei Jiang; Xulin Jiang; Yu Zhang; Jun Xiao
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.